State Street Corp Denali Therapeutics Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 4,252,011 shares of DNLI stock, worth $104 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,252,011
Previous 4,434,790 4.12%
Holding current value
$104 Million
Previous $103 Million 20.28%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$20.96 - $31.05 $3.83 Million - $5.68 Million
-182,779 Reduced 4.12%
4,252,011 $124 Million
Q2 2024

Aug 14, 2024
SELL
$14.96 - $23.22 $28.3 Million - $43.9 Million
-1,889,082 Reduced 29.87%
4,434,790 $103 Million
Q1 2024

May 15, 2024
BUY
$15.83 - $23.35 $13.3 Million - $19.6 Million
837,924 Added 15.27%
6,323,872 $130 Million
Q4 2023

Feb 14, 2024
BUY
$16.2 - $23.18 $19.6 Million - $28.1 Million
1,210,620 Added 28.32%
5,485,948 $118 Million
Q3 2023

Nov 14, 2023
SELL
$20.63 - $30.17 $3.98 Million - $5.83 Million
-193,163 Reduced 4.32%
4,275,328 $88.2 Million
Q2 2023

Aug 14, 2023
SELL
$23.37 - $32.96 $2.87 Million - $4.05 Million
-122,898 Reduced 2.68%
4,468,491 $132 Million
Q1 2023

May 15, 2023
SELL
$21.91 - $32.67 $5.57 Million - $8.31 Million
-254,421 Reduced 5.25%
4,591,389 $106 Million
Q4 2022

Feb 14, 2023
BUY
$26.28 - $33.92 $17.2 Million - $22.2 Million
653,582 Added 15.59%
4,845,810 $135 Million
Q3 2022

Nov 15, 2022
BUY
$25.97 - $38.53 $11.5 Million - $17 Million
441,528 Added 11.77%
4,192,228 $129 Million
Q2 2022

Aug 15, 2022
SELL
$20.88 - $35.19 $1.59 Million - $2.68 Million
-76,092 Reduced 1.99%
3,750,700 $110 Million
Q1 2022

May 16, 2022
BUY
$29.0 - $47.27 $23.2 Million - $37.8 Million
799,221 Added 26.4%
3,826,792 $123 Million
Q4 2021

Feb 14, 2022
BUY
$42.59 - $55.02 $9.77 Million - $12.6 Million
229,437 Added 8.2%
3,027,571 $135 Million
Q3 2021

Nov 15, 2021
BUY
$48.48 - $78.23 $23.2 Million - $37.4 Million
477,674 Added 20.59%
2,798,134 $141 Million
Q2 2021

Aug 16, 2021
BUY
$50.3 - $78.44 $15.3 Million - $23.8 Million
303,793 Added 15.06%
2,320,460 $182 Million
Q1 2021

May 17, 2021
SELL
$53.8 - $81.53 $2.71 Million - $4.11 Million
-50,406 Reduced 2.44%
2,016,667 $115 Million
Q4 2020

Feb 16, 2021
SELL
$36.89 - $93.56 $6.95 Million - $17.6 Million
-188,526 Reduced 8.36%
2,067,073 $173 Million
Q3 2020

Nov 10, 2020
BUY
$23.13 - $38.84 $238,678 - $400,789
10,319 Added 0.46%
2,255,599 $80.8 Million
Q2 2020

Aug 14, 2020
BUY
$16.01 - $28.82 $8.89 Million - $16 Million
555,524 Added 32.88%
2,245,280 $54.3 Million
Q1 2020

May 11, 2020
BUY
$14.2 - $27.98 $24 Million - $47.3 Million
1,689,756 New
1,689,756 $29.6 Million

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.28B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email